Bacillus_Calmette-Guerin_and_interleukin-2_for_treatment_of_superficial_bladder_cancer._A_total_of_22_patients_with_bladder_cancer_received_bacillus_Calmette-Guerin_(BCG)_and_interleukin-2._Significant_bladder_tumor_remissions_were_noted_in_15_of_17_patients_(88%)._Of_5_patients_with_carcinoma_in_situ_1_was_noncompliant_and_he_died_of_carcinoma_in_situ._The_other_4_patients_are_in_remission._BCG_alone_was_instilled_in_22_additional_patients_with_superficial_bladder_cancer._The_remission_rates_were_encouraging._Of_the_22_patients_13_(59%)_had_remission_of_the_bladder_tumor._A_half_dose_of_BCG_(60_mg.)_is_adequate_when_given_weekly_for_6_weeks._Maintenance_therapy_is_important_as_noted_in_both_of_our_clinical_arms._BCG_and_interleukin-2_therapy_results_in_a_higher_remission_rate.